BioAge Labs (BIOA) Invested Capital (2023 - 2026)

BioAge Labs has disclosed Invested Capital across 4 years of filings, most recently posting $379.6 million for Q1 2026.

• Invested Capital for Q1 2026 came in at $379.6 million, up 18.94% year-over-year; the trailing twelve-month figure through Mar 2026 was $379.6 million (up 18.94% YoY), and the FY2025 annual result was $274.1 million, down 16.73% from the prior year.
• Invested Capital came in at $379.6 million for Q1 2026 at BioAge Labs, up from $274.1 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $379.6 million in Q1 2026 to a low of -$197.1 million in Q2 2024.
• The 4-year median for Invested Capital is $281.0 million (2025), against an average of $136.3 million.
• Across the five-year window, Invested Capital soared 308.8% in 2024 and retreated 16.73% in 2025, its largest moves.
• BioAge Labs' Invested Capital stood at -$167.4 million in 2023, then jumped by 296.62% to $329.1 million in 2024, then retreated by 16.73% to $274.1 million in 2025, then surged by 38.52% to $379.6 million in 2026.
• The last three Invested Capital figures came in at $379.6 million (Q1 2026), $274.1 million (Q4 2025), and $281.0 million (Q3 2025), per Business Quant data.